The regulation of BAs on other pathways occurs mainly through the activation of nuclear hormone receptors ( NHRs ) such as the farnesoid X receptor ( FXR ) , pregnane X receptor ( PXR ) , and vitamin D receptor ( VDR ) .
1,2 person
1,8 abstract|4,5 object|6,8 abstract|11,17 event|27,28 object|34,35 object

It is widely expressed in the body , for example in the gallbladder , ileum , colon , liver ( not in hepatocytes though ) , brown adipose tissue ( BAT ) , nervous system , and muscle .
1,2 person
1,2 substance|6,8 place|12,20 place

Besides being involved in BA , glucose , and lipid metabolism , interestingly , it also plays a role in increasing the induction of BAT expression in thermogenesis and energy release via browning of white adipose tissue and .
1,2 person
5,6 substance|5,12 abstract|7,8 substance|15,16 abstract|18,20 abstract|18,27 abstract|25,27 abstract|30,31 substance|30,32 abstract|35,38 object

After being activated through BA in the ileum , the expression of fibroblast growth factor 15/19 ( FGF15/19 ) increases , leading to an activation of fibroblast growth factor receptor 4 ( FGFR4 ) in hepatocytes (
1,2 person
5,6 substance|7,9 place|10,17 abstract|24,32 event|27,32 abstract

In another experiment , TGR5 knockout mice received a sleeve gastrectomy and it was shown how TGR5 is important in order to decrease hepatic steatosis , improve glucose control , and increase the energy expenditure post-surgery .
1,2 person
2,4 abstract|5,8 abstract|9,12 event|9,12 object|10,12 object|24,26 abstract|28,29 substance|28,30 abstract|33,36 abstract

TGR5 knockout leads to a changed BA composition and has anti-inflammatory properties by for example by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells ( NF-κB ) or LPS-induced production of inflammatory cytokines in macrophages .
1,2 person
1,2 event|1,3 abstract|5,9 abstract|7,9 abstract|11,13 abstract|35,36 object

A lack of FGF 15 results in increased hepatic steatosis and in the development of endoplasmic reticulum ( ER ) stress in the liver of mice fed a high fat diet .
1,2 person
1,6 abstract|4,6 abstract|4,6 substance|8,11 abstract|9,11 abstract|13,22 abstract|16,22 abstract|26,27 animal|28,32 abstract|28,32 substance

Despite the fact that LCA is a weak activator of FXR , it is a very strong downregulator of its function and thus could be termed a partial agonist .
1,2 person
2,6 abstract|7,12 abstract|11,12 abstract|20,22 abstract|27,30 abstract

This is of great importance as FGF15/19 is an ileum-derived enterokine that governs BA homeostasis , regulates hepatic glucose metabolism , and stimulates protein synthesis .
1,2 person
1,2 abstract|4,6 abstract|14,15 substance|14,16 abstract|24,25 substance|24,26 abstract

Afterwards , they act on various regulatory regions by binding to hormone response elements causing several genes to be up or downregulated in their transcription .
1,2 person
3,4 animal|6,9 place|12,15 abstract|16,18 abstract|24,25 abstract|24,26 abstract

It also regulates the expression of peroxisome proliferator-activated receptor PPAR-α , a regulator of triglyceride metabolism , that can induce free fatty acid β-oxidation .
1,2 person
1,2 abstract|4,11 abstract|15,17 abstract

For the activation of these receptors , it is necessary that they interact with the retinoid X receptor as a heterodimer ( RXR ) .
1,2 person
2,7 event|5,7 object

If administered pharmacologically or expressed transgenically in mice , FGF19 increases hepatic lipid oxidation , reduces lipogenesis and protects from hepatosteatosis .
1,2 person
8,9 animal|10,11 abstract

The activation of FGFR4 together with the activation of small heterodimer partner ( SHP ) in the liver , inhibits CYP7A1 .
1,2 person
1,13 abstract|7,13 abstract|17,19 object|17,19 place

On the other hand , the liver-specific FXR plays an important role in the repression of the expression of CYP8B1 .
1,2 person
14,21 event|17,21 abstract

LCA is considered to be the strongest activator of TGR5 among the main primary and secondary BAs .
1,2 person
10,11 abstract|12,18 abstract

Most BAs and the secondary BA , and LCA , are binding to FXR and PXR respectively .
1,2 person


It is most highly expressed in the liver , ileum , kidneys , and adrenal glands .
1,2 person
15,17 object

FXR influences the hepatic lipid homeostasis via SHP , which reduces the expression of SREBP1 .
1,2 person
3,7 abstract|8,9 abstract|12,16 abstract

Controlling the synthesis and enterohepatic circulation of BAs , represents the major function of FXR .
1,2 person
8,9 substance|11,16 abstract

The strongest activator is CDCA , followed by DCA , CA , and LCA .
1,2 person
1,4 abstract|5,6 object|9,15 abstract|14,15 abstract

One of the mechanisms for BAs to suppress their own synthesis is through FXR .
1,2 person
1,5 abstract|6,7 substance|9,12 abstract

FXR plays an important role in BA , glucose , and lipid metabolism .
1,2 person
3,14 abstract|7,8 substance|7,14 abstract|9,10 substance|12,14 abstract

In the liver , bile flow is prompted through FXR activation .
1,2 person
2,4 object|2,4 place|5,7 abstract|10,12 abstract

In order to downregulate CYP7A1 , intestinal-specific FXR is required .
1,2 person
7,9 substance

TGR5 is a G-protein coupled membrane receptor that BAs activate .
1,2 person
1,2 event

BA targeted therapy is based on their receptors and ligands .
1,2 person
1,4 abstract|7,11 abstract

A lack of it causes impaired liver regeneration .
1,2 person
4,5 substance|6,9 abstract|7,8 object

Takeda G-Protein-Coupled Receptor 5 ( TGR5 )
1,2 person
1,2 person|1,5 abstract|6,7 abstract

Typical Ligands for Bile Acids
1,2 person


2.1 .
1,2 person
1,2 abstract

2.2 .
1,2 person
1,2 abstract

2 .
1,2 person


Figure 1
1,2 person
1,3 object

) .
1,2 person


FXR
1,2 person
1,2 abstract
